Eye Health Supplements Market Size, Share & Trends Analysis Report By Ingredient Type (Lutein & Zeaxanthin, Antioxidants), By Indication (AMD, Cataract), By Formulation, By Region, And Segment Forecasts, 2024 - 2030

Eye Health Supplements Market Size, Share & Trends Analysis Report By Ingredient Type (Lutein & Zeaxanthin, Antioxidants), By Indication (AMD, Cataract), By Formulation, By Region, And Segment Forecasts, 2024 - 2030


Eye Health Supplements Market Growth & Trends

The global eye health supplements market size is expected to reach USD 2.94 billion by 2030, expanding at a CAGR of 7.06%, according to a new report by Grand View Research, Inc. Rising elderly population, growing exposure to blue light, and increasing prevalence of various vision disorders such as macular degeneration, refractive errors, cataract, inflammation, diabetic retinopathy, corneal opacity, trachoma, and dry eye syndrome are the major factors driving the market. In addition, uneven quality of eye care services, workforce shortages, lifestyle changes leading to less time spent outdoors, poor nutritional habits and dropping food quality, and increasing awareness regarding eye health is further boosting the market growth.

According to the World Health Organization, in 2019, 2.2 billion people were suffering from vision impairments or blindness globally, out of which 1.0 billion people have moderate to severe distance vision impairment. This is owing to unaddressed cataract accounting for 65.2 million, refractive error accounting for 123.7 million, glaucoma accounting for 6.9 million, diabetic retinopathy accounting for 3.0 million, trachoma accounting for 2.0 million, and corneal opacities accounting for 4.2 million, as well as near vision impairment caused due to unaddressed presbyopia accounting for 826.0 million cases. This has led to the rise in the demand and adoption of the supplements for the prevention of various vision-related problems.

Moreover, an increase in the number of product launches, partnerships, collaborations, mergers and acquisitions, and government initiatives is further boosting the market growth. For instance, in November 2019, NovaBay Pharmaceuticals, Inc. announced the launch of NovaSight, formulated to support ocular health, on Amazon.com. In January 2020, VisiVite announced the launch of two new supplements- VisiVite Blue Light Basher Formula for replenishing the macular pigment layer and dissipating high energy blue light, and VisiVite AREDS 2 Chewable Tablets for maximum ocular nutrition. However, lack of product availability and high costs associated with the supplements in emerging countries is anticipated to hamper the market growth.

Eye Health Supplements Market Report Highlights
  • lutein & zeaxanthin ingredients for eye health supplements accounted for the largest revenue share of 33.10% in 2023.
  • The Age-related Macular Degeneration (AMD) segment accounted for the largest revenue share in 2023. Whereas, the dry eye syndrome segment is projected to expand at the fastest CAGR during the forecast period.
  • Based on formulation, the tablets segment accounted for the largest revenue share in 2023, whereas the softgels segment is projected to expand at the fastest CAGR during the forecast period.
  • North America accounted for the largest revenue share in 2023 due to increasing prevalence of eye-related disorders in the region, developed healthcare infrastructure, and a high presence of channel distributors for the supplements.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Ingredient Type Segment
1.1.2. Indication Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objective
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing awareness about the importance of eye health
3.2.1.2. Rising incidence of eye disorders
3.2.1.3. Growing geriatric population
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of standardization
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Ingredient Type Group Business Analysis
4.1. Indication Segment Dashboard
4.2. Eye Health Supplements Market Ingredient Type Movement Analysis
4.3. Eye Health Supplements Market Size & Trend Analysis, by Ingredient Type, 2018 to 2030 (USD Million)
4.4. Lutein and Zeaxanthin
4.4.1. Lutein and zeaxanthin market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Antioxidants
4.5.1. Antioxidants market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Omega-3 Fatty Acids
4.6.1. Omega-3 fatty acids market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Coenzyme Q10
4.7.1. Coenzyme Q10 market estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Flavonoids
4.8.1. Flavonoids market estimates and forecasts, 2018 - 2030 (USD Million)
4.9. Alpha-Lipoic Acid
4.9.1. Alpha-lipoic acid market estimates and forecasts, 2018 - 2030 (USD Million)
4.10. Astaxanthin
4.10.1. Astaxanthin market estimates and forecasts, 2018 - 2030 (USD Million)
4.11. Others
4.11.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Indication Group Business Analysis
5.1. Indication Segment Dashboard
5.2. Eye Health Supplements Market Indication Movement Analysis
5.3. Eye Health Supplements Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
5.4. Age-related Macular Degeneration (AMD)
5.4.1. Age-related macular degeneration (AMD) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Cataract
5.5.1. Cataract market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Dry Eye Syndrome
5.6.1. Dry eye syndrome market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Inflammation
5.7.1. Inflammation market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Formulation Business Analysis
6.1. Formulation Segment Dashboard
6.2. Eye Health Supplements Market Formulation Movement Analysis
6.3. Eye Health Supplements Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
6.4. Tablets
6.4.1. Tablets market estimates and forecasts, 2018–2030 (USD Million)
6.5. Capsules
6.5.1. Capsules market estimates and forecasts, 2018–2030 (USD Million)
6.6. Powder
6.6.1. Powder market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Softgels
6.7.1. Softgels market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. Liquid
6.8.1. Liquid market estimates and forecasts, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis by Ingredient Type, Indication, Formulation
7.1. Regional Dashboard
7.2. Market Size & Forecast and Trend Analysis, 2023 & 2030
7.3. North America
7.3.1. North America Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Denmark Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. MEA Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE Eye Health Supplements Market, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait Eye Health Supplements Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. The Nature's Bounty Co.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Vitabiotics Ltd.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Pfizer Inc
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Amway International
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bausch & Lomb
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Nutrivein
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. ZeaVision LLC
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Kemin Industries, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. EyeScience
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Nutrachamps
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings